Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2013. Start Trial.
Date Value
October 23, 2026 0.0141
October 22, 2026 0.0141
October 21, 2026 0.0141
October 20, 2026 0.0141
October 19, 2026 0.0141
October 16, 2026 0.0141
October 15, 2026 0.0141
October 14, 2026 0.0141
October 13, 2026 0.0141
October 12, 2026 0.0141
October 09, 2026 0.0141
October 08, 2026 0.0141
October 07, 2026 0.0141
October 06, 2026 0.0141
October 05, 2026 0.0141
October 02, 2026 0.0141
October 01, 2026 0.0141
September 30, 2026 0.0141
September 29, 2026 0.0141
September 28, 2026 0.0141
September 25, 2026 0.0141
September 24, 2026 0.0141
September 23, 2026 0.0141
September 22, 2026 0.0141
September 21, 2026 0.0141
Date Value
September 18, 2026 0.0141
September 17, 2026 0.0141
September 16, 2026 0.0141
September 15, 2026 0.0141
September 14, 2026 0.0141
September 11, 2026 0.0141
September 10, 2026 0.0141
September 09, 2026 0.0141
September 08, 2026 0.0141
September 04, 2026 0.0141
September 03, 2026 0.0141
September 02, 2026 0.0141
September 01, 2026 0.0141
August 31, 2026 0.0141
August 28, 2026 0.0141
August 27, 2026 0.0141
August 26, 2026 0.0141
August 25, 2026 0.0141
August 24, 2026 0.0141
August 21, 2026 0.0141
August 20, 2026 0.0141
August 19, 2026 0.0141
August 18, 2026 0.0141
August 17, 2026 0.0141
August 14, 2026 0.0141

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
InflaRx NV 1.376
BioNTech SE 1.090
Immatics NV 2.187
Arrowhead Pharmaceuticals, Inc. 17.59
Oncolytics Biotech, Inc. --

Price to Book Value Related Metrics

Price 0.10
Market Cap 1.474M